EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interleukin‐6 positively correlates with cardiovascular disease predictor algorithms and biomarker in rheumatoid arthritis patients

Seyed Askar Roghani, Afsaneh Shamsi, Cyrus Jalili, Farnaz Jalili, Ramin Lotfi iD, Nima Garman, Rezvan Rostampour, Mahdi Taghadosi iD

Journal of Cellular and Molecular Medicine · 2024-08 · 28 (16)

DOI: 10.1111/jcmm.70028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 19.08.2024. Verfasst von Seyed Askar Roghani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Biomarkers, Interleukin-6, Cardiovascular Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deputy for Research and Technology, Kermanshah University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammation is believed as the main culprit of the link between cardiovascular disease (CVD) and rheumatoid arthritis (RA). Interleukin‐6 (IL‐6) is a pro‐inflammatory cytokine with a key role in RA pathophysiology and also correlates with joint destruction and disease activity. This study evaluates the association between IL‐6 plasma level and cardiac biomarker NT‐proBNP, HS‐CRP, CVD predictor algorithms, Framingham Risk Score (FRS) and Systematic Coronary Risk Evaluation (SCORE), as well as with CXCL9 and its receptor, CXCR3 in RA patients compared to the controls. Sixty RA patients (30 early and 30 late) and 30 healthy persons were included in this study. IL‐6 and NT‐proBNP plasma levels were measured by the ELISA. Also, HS‐CRP plasma levels were quantified using the immunoturbidimetric assay. The CVD risk was assessed by the FRS and SCORE. IL‐6 plasma levels were significantly higher in the early and late RA patients compared to the controls ( p < 0.001). There was a positive correlation between IL‐6 with DAS‐28 ( p = 0.007, r = 0.346), BPS ( p = 0.002, r = 0.396), BPD ( p = 0.046, r = 0.259), SCORE ( p < 0.001, r = 0.472), and FRS ( p < 0.001, r = 0.553), and a negative association with HDL ( p = 0.037, r = −0.270), in the patients. Also, IL‐6 plasma level positively correlated with HS‐CRP ( p = 0.021, r = 0.297) and NT‐proBNP ( p = 0.045, r = 0.260) in the patients. Furthermore, a positive association was found between IL‐6 plasma levels and CXCL9 ( p = 0.002, r = 0.386), and CXCR3 ( p = 0.018, r = 0.304) in the patients. Given the interesting association between IL‐6 with various variables of CVD, IL‐6 may be considered a biomarker for assessing the risk for future cardiovascular events in RA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidBiomarkersInterleukin-6Cardiovascular DiseasesNatriuretic Peptide, BrainC-Reactive ProteinAlgorithmsPeptide FragmentsHumansFemaleMaleMiddle AgedChemokine CXCL9AdultCase-Control StudiesAgedRisk FactorsReceptors, CXCR3

Stichwörter der Autor:innen

CXCR3C‐reactive proteinInterleukin‐6cardiovascular diseaserheumatoid arthritis

Substanzen

BiomarkersInterleukin-6Natriuretic Peptide, Brainpro-brain natriuretic peptide (1-76)C-Reactive ProteinPeptide FragmentsChemokine CXCL9CXCR3 protein, humanIL6 protein, humanCXCL9 protein, human

Autor:innen und Institutionen

  • Immunology Department, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • University of Adelaide, Adelaide, South Australia, Australia.
  • Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
  • Clinical Research Development Center, Tohid Hospital, Kurdistan University of Medical Sciences, Sanandaj, Iran.

ORCID-Profile: Ramin Lotfi, Mahdi Taghadosi

Förderung

  • Deputy for Research and Technology, Kermanshah University of Medical Sciences

Zitieren

APA

Roghani, S. A., Shamsi, A., Jalili, C., Jalili, F., Lotfi, R., Garman, N., Rostampour, R., & Taghadosi, M. (2024). Interleukin‐6 positively correlates with cardiovascular disease predictor algorithms and biomarker in rheumatoid arthritis patients. Journal of Cellular and Molecular Medicine, 28(16). https://doi.org/10.1111/jcmm.70028

Vancouver

Roghani SA, Shamsi A, Jalili C, Jalili F, Lotfi R, Garman N, et al. Interleukin‐6 positively correlates with cardiovascular disease predictor algorithms and biomarker in rheumatoid arthritis patients. Journal of Cellular and Molecular Medicine. 2024;28(16). doi:10.1111/jcmm.70028

BibTeX
@article{Roghani2024,
  author = {Roghani, Seyed Askar and Shamsi, Afsaneh and Jalili, Cyrus and Jalili, Farnaz and Lotfi, Ramin and Garman, Nima and Rostampour, Rezvan and Taghadosi, Mahdi},
  title = {Interleukin‐6 positively correlates with cardiovascular disease predictor algorithms and biomarker in rheumatoid arthritis patients},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  volume = {28},
  number = {16},
  doi = {10.1111/jcmm.70028}
}
Kostenlos starten →